MoneyWorks4Me

Nectar Lifesciences informs about annual report

24 Aug 2021 Evaluate
Pursuant to regulations 30 and 34 of SEBI (Listing Obligations and Disclosures Requirement) Regulations 2015, Nectar Lifesciences has informed that it enclosed Annual Report for the financial year 2020-21.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..